Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Recent Study: Diabetic Neuropathy - Pipeline Review, H1 2013


Print article Print article
2013-03-29 11:32:10 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Diabetic Neuropathy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Neuropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Neuropathy. Diabetic Neuropathy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/556440_diabetic_neuropathy_pipeline_review_h ..


Note*: Certain sections in the report may be removed or altered based on the

availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Diabetic Neuropathy.
* A review of the Diabetic Neuropathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Diabetic Neuropathy pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Diabetic Neuropathy.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Diabetic Neuropathy pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Diabetic Neuropathy Overview
Therapeutics Development
An Overview of Pipeline Products for Diabetic Neuropathy
Diabetic Neuropathy Therapeutics under Development by Companies
Diabetic Neuropathy Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Diabetic Neuropathy Therapeutics - Products under Development by Companies
Diabetic Neuropathy Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Diabetic Neuropathy Therapeutics Development
Merck & Co., Inc.
Dainippon Sumitomo Pharma Co., Ltd.
Takeda Pharmaceutical Company Limited
Dong-A Pharmaceutical Co., Ltd.
Glenmark Pharmaceuticals Ltd.
Sigma-Tau S.p.A.
Lpath, Inc.
NeurogesX, Inc.
Torrent Pharmaceuticals Limited
R-Tech Ueno, Ltd.
Neurotune AG
Arcion Therapeutics, Inc.
Creative Peptides Sweden AB
Intellect Neurosciences, Inc.
Glucox Biotech
Viromed Co., Ltd.
Vascular Pharmaceuticals, Inc.
Cebix Incorporated
TheraQuest Biosciences, LLC
Beech Tree Labs, Inc.
Diabetic Neuropathy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ranirestat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TAK-428 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lpathomab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NT-13317 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NGX-4010 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VM-202 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proinsulin C-peptide (human) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RTU-1096 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
levocarnitine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
clonidine hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
IN-N01 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DA-3030 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
filorexant - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GRC-17536 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TRC-4149 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
mepivacaine hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NT-24336 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ersatta - Drug Profile
Product Description
Mechanism of Action
R&D Progress

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=556440&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com